Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | -9.85%490.75M | -10.49%1.98B | -22.24%1.4B | -25.91%954.48M | -15.08%544.36M | -20.77%2.21B | -17.40%1.8B | -2.64%1.29B | 8.34%641.01M | 44.72%2.79B |
Refunds of taxes and levies | 25.67%29.48M | -27.33%99.73M | -46.84%63.62M | -55.92%43.11M | -57.16%23.46M | -47.89%137.23M | -46.80%119.67M | -42.80%97.79M | 94.18%54.76M | 251.43%263.34M |
Cash received relating to other operating activities | -54.35%5.12M | -0.56%20.52M | -35.89%23.8M | -8.94%19.67M | -5.59%11.22M | -20.24%20.63M | 20.12%37.12M | 16.23%21.6M | 25.60%11.89M | -6.15%25.87M |
Cash inflows from operating activities | -9.27%525.36M | -11.38%2.1B | -24.00%1.49B | -27.73%1.02B | -18.17%579.04M | -23.08%2.37B | -19.64%1.96B | -6.95%1.41B | 12.45%707.65M | 51.65%3.08B |
Goods services cash paid | 23.44%479.3M | -9.14%1.68B | -25.99%1.18B | -20.48%849.36M | -38.64%388.3M | -15.32%1.85B | 0.08%1.59B | 3.71%1.07B | 54.52%632.82M | 53.41%2.19B |
Staff behalf paid | 2.43%62.34M | -1.73%238.12M | 1.25%182.83M | -6.01%124.75M | -2.61%60.86M | 23.02%242.31M | 20.41%180.56M | 29.60%132.73M | 13.53%62.49M | 12.48%196.96M |
All taxes paid | 7.25%5.12M | -59.33%12.12M | -48.07%17.64M | -31.23%10.61M | -69.11%4.77M | -39.57%29.8M | -24.30%33.97M | -49.95%15.42M | -5.48%15.44M | 84.42%49.32M |
Cash paid relating to other operating activities | -62.44%19.75M | -13.90%213.23M | -49.22%74.92M | -51.11%45.52M | 39.47%52.59M | -12.94%247.65M | -23.15%147.55M | -9.40%93.1M | 8.78%37.71M | 57.29%284.45M |
Cash outflows from operating activities | 11.84%566.51M | -9.51%2.15B | -25.61%1.45B | -21.31%1.03B | -32.32%506.52M | -12.73%2.37B | -1.19%1.95B | 3.43%1.31B | 45.17%748.45M | 50.29%2.72B |
Net cash flows from operating activities | -156.75%-41.15M | -4,956.63%-45.03M | 368.20%37.53M | -113.19%-12.97M | 277.74%72.52M | -100.24%-890.43K | -98.27%8.01M | -60.17%98.32M | -135.87%-40.8M | 62.62%364.45M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | 7.26%587.53M | -18.99%2.39B | -14.84%1.73B | -18.17%1.19B | -22.42%547.75M | -31.93%2.95B | -28.28%2.04B | -18.27%1.46B | -2.20%706.03M | 57.27%4.34B |
Cash received from returns on investments | -34.71%541.06K | -26.48%5.83M | 0.85%4.52M | -4.12%2.89M | -3.41%828.69K | -24.93%7.93M | -31.48%4.48M | -12.55%3.01M | -83.26%857.92K | -42.49%10.56M |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | -71.66%429.59K | -77.80%186.35K | -78.05%131.1K | ---- | -20.93%1.52M | -53.73%839.29K | -52.96%597.37K | -89.78%127.75K | 59.62%1.92M |
Cash inflows from investing activities | 7.20%588.07M | -19.04%2.4B | -14.83%1.74B | -18.16%1.2B | -22.41%548.58M | -31.91%2.96B | -28.31%2.04B | -18.28%1.46B | -2.92%707.01M | 56.61%4.35B |
Cash paid to acquire fixed assets intangible assets and other long-term assets | 174.98%58.13M | -2.39%187.15M | -38.97%94.39M | -28.71%77.03M | -58.05%21.14M | -35.63%191.73M | -11.84%154.66M | 9.71%108.05M | 4.20%50.39M | 50.25%297.87M |
Cash paid to acquire investments | -1.78%743.98M | -18.48%2.4B | -16.13%1.92B | -18.06%1.32B | -10.12%757.45M | -31.27%2.95B | -29.73%2.29B | -23.41%1.61B | -13.81%842.71M | 59.27%4.29B |
Cash outflows from investing activities | 3.02%802.11M | -17.49%2.59B | -17.58%2.01B | -18.73%1.4B | -12.82%778.59M | -31.55%3.14B | -28.81%2.44B | -21.93%1.72B | -12.96%893.1M | 58.65%4.58B |
Net cash flows from investing activities | 6.94%-214.04M | -9.04%-188.12M | 31.55%-273.93M | 21.90%-203.21M | -23.61%-230.01M | 24.77%-172.52M | 31.28%-400.21M | 37.56%-260.21M | 37.50%-186.08M | -110.74%-229.33M |
Financing cash flow | ||||||||||
Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4.9M |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4.9M |
Cash from borrowing | 66.52%169.85M | 12.10%405.32M | 22.77%344.7M | 8.75%214M | 11.50%102M | 80.79%361.58M | 100.56%280.78M | 40.56%196.78M | 1.64%91.48M | 566.67%200M |
Cash received relating to other financing activities | ---- | -57.01%7.87M | ---- | ---- | ---- | --18.31M | ---- | ---- | ---- | ---- |
Cash inflows from financing activities | 66.52%169.85M | 8.77%413.19M | 22.77%344.7M | 8.75%214M | 11.50%102M | 85.40%379.89M | 100.56%280.78M | 40.56%196.78M | 1.64%91.48M | 583.00%204.9M |
Borrowing repayment | -46.48%53.25M | 96.34%284.85M | 224.96%314.5M | 172.80%164.5M | --99.5M | 3.63%145.08M | 61.30%96.78M | 101.00%60.3M | ---- | --140M |
Dividend interest payment | -19.37%3.2M | -87.04%10.94M | -89.77%8.49M | -93.12%5.53M | 254.43%3.97M | 43.06%84.39M | 43.40%83M | 40.20%80.44M | 175.62%1.12M | 5.47%58.99M |
Cash payments relating to other financing activities | ---- | ---- | 332.42%505.75K | ---- | ---- | -99.84%116.96K | 12.60%116.96K | ---- | ---- | -9.45%74.39M |
Cash outflows from financing activities | -45.44%56.45M | 28.83%295.78M | 79.82%323.5M | 20.81%170.03M | 9,146.17%103.47M | -16.02%229.59M | 52.48%179.9M | 61.08%140.74M | 175.62%1.12M | 97.98%273.38M |
Net cash flows from financing activities | 7,834.36%113.4M | -21.88%117.41M | -78.98%21.2M | -21.54%43.97M | -101.62%-1.47M | 319.49%150.3M | 358.24%100.88M | 6.49%56.04M | 0.86%90.36M | 36.64%-68.48M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | 53.44%3.81M | 203.93%7.92M | 206.80%5.7M | 382.82%6.37M | 138.05%2.48M | -114.51%-7.62M | -10.14%-5.34M | -174.92%-2.25M | -189.28%-6.53M | 738.16%52.54M |
Net increase in cash and cash equivalents | 11.82%-137.98M | -250.83%-107.81M | 29.38%-209.5M | -53.40%-165.84M | -9.38%-156.48M | -125.78%-30.73M | -192.25%-296.65M | 5.38%-108.11M | -64.29%-143.05M | 11,672.73%119.19M |
Add:Begin period cash and cash equivalents | -34.69%311.8M | -6.82%419.62M | -6.82%419.62M | -6.82%419.62M | 6.54%477.41M | 35.99%450.35M | 35.99%450.35M | 35.99%450.35M | 35.31%448.11M | -0.31%331.16M |
End period cash equivalent | -45.84%173.82M | -25.69%311.8M | 36.71%210.12M | -25.85%253.78M | 5.21%320.94M | -6.82%419.62M | -33.07%153.7M | 57.77%342.24M | 24.97%305.06M | 35.99%450.35M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Zheng Dan Zhiyuan (Shenzhen) Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.